Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
JAGSNPHARM.NSthis companyJagsonpal Pharmaceuticals Limited	₹217.42	29.01×	4.53×	4.35×	18.35×	83.7%	63.7%	16.9%	15.0%	15.6%	12.6%	3.7%	0.03×	-0.03×	47.31×	5.06×	1.3%	5	13.66	4	A
BABAJAJHCARE.BOBajaj Healthcare Ltd	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
BAJAJHCARE.NSBajaj Healthcare Ltd	₹315.25	58.25×	1.72×	1.5×	14.35×	-51.1%	33.4%	12.6%	2.6%	3.0%	7.2%	-0.7%	0.47×	2.68×	3.48×	1.71×	0.3%	2	2.61	2	C+
BLBLISSGVS.BOBliss GVS Pharma Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
BLISSGVS.NSBliss GVS Pharma Limited	₹654.75	18.76×	2.03×	2.61×	10.25×	-99.6%	54.2%	14.1%	13.9%	10.8%	7.3%	3.4%	0.02×	-0.06×	10.87×	4.02×	0.4%	6	17.76	3	B
HEHESTERBIO.BOHester Biosciences Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Peer median	—	38.51×	1.88×	2.06×	12.3×	-75.3%	43.8%	13.4%	8.3%	6.9%	7.3%	1.4%	0.24×	1.31×	7.17×	2.86×	0.4%	4	10.18	3	—